Mitigating Doxorubicin-Induced Cardiotoxicity through Quercetin Intervention: An Experimental Study in Rats
Doxorubicin (DOX) is an effective anticancer drug, but its use is limited by dose-dependent heart toxicity. Quercetin is a natural antioxidant frequently studied for its beneficial properties. Moreover, a wide range of dietary supplements are available for human use. This in vivo study aimed to expl...
Salvato in:
Autori principali: | Patricia Lorena Dulf (Autore), Camelia Alexandra Coadă (Autore), Adrian Florea (Autore), Remus Moldovan (Autore), Ioana Baldea (Autore), Daniel Vasile Dulf (Autore), Dan Blendea (Autore), Adriana Gabriela Filip (Autore) |
---|---|
Natura: | Libro |
Pubblicazione: |
MDPI AG,
2024-08-01T00:00:00Z.
|
Soggetti: | |
Accesso online: | Connect to this object online. |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi
Documenti analoghi
-
Reduction of Doxorubicin-Induced Cardiotoxicity by Co-Administration of Smart Liposomal Doxorubicin and Free Quercetin: In Vitro and In Vivo Studies
di: Hamidreza Dorostkar, et al.
Pubblicazione: (2023) -
Doxorubicin Cardiotoxicity: An Update Regarding the Mechanism of Toxicity and Mitigation Strategies of Bee Propolis
di: Hodhaifa Abdul Mohsin, et al.
Pubblicazione: (2023) -
Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy
di: Lan Li, et al.
Pubblicazione: (2017) -
Albumin-Based Zn (II)-Quercetin Enzyme Mimic Scavenging ROS for Protection against Cardiotoxicity Induced by Doxorubicin
di: Zehua Shao, et al.
Pubblicazione: (2022) -
Goji-Berry-Mediated Green Synthesis of Gold Nanoparticles and Their Promising Effect on Reducing Oxidative Stress and Inflammation in Experimental Hyperglycemia
di: Luminita David, et al.
Pubblicazione: (2023)